Skip to content
Search

Latest Stories

17 more added to December price concessions

The Department of Health and Social Care on Friday (December 18) included 17 drugs in its second price concessions list for December 2020.

DrugPack SizePrice Concession
Ciprofloxacin 500mg tablets10£3.30
Desmopressin 10micrograms/dose nasal spray60 dose£22.81
Docusate 12.5mg/5ml oral solution sugar free300ml£13.19
Docusate 50mg/5ml oral solution sugar free300ml£13.39
Docusate 100mg capsules30£3.20
Entacapone 200mg tablets30£8.12
Eplerenone 25mg tablets28£8.20
Eplerenone 50mg tablets28£7.79
Esomeprazole 40mg gastro-resistant capsules28£3.01
Esomeprazole 20mg gastro-resistant tablets28£5.58
Lamotrigine 200mg tablets56£5.08
Olmesartan medoxomil 10mg tablets28£3.09
Olmesartan medoxomil 40mg tablets28£3.79
Sulfasalazine 500mg gastro-resistant tablets112£11.95
Sulfasalazine 500mg tablets112£7.20
Trimethoprim 100mg tablets28£2.07
Zonisamide 100mg capsules56£61.16

Previous drug price concessions list released for December 2020.


DrugPack SizePrice Concession
Ciprofloxacin 250mg tablets10£1.50
Duloxetine 20mg gastro-resistant capsules28£8.48
Duloxetine 30mg gastro-resistant capsules28£1.90
Duloxetine 40mg gastro-resistant capsules56£13.69
Duloxetine 60mg gastro-resistant capsules28£3.99
Enalapril 10mg tablets28£5.50
Enalapril 20mg tablets28£9.63
Hydrocortisone 2.5% cream15g£44.00
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets28£14.31
Lamotrigine 100mg tablets56£6.50
Lamotrigine 25mg tablets56£1.95
Lamotrigine 50mg tablets56£3.99
Moxonidine 200microgram tablets28£8.52
Moxonidine 300microgram tablets28£8.22
Moxonidine 400microgram tablets28£7.30
Olanzapine 10mg tablets28£2.75
Olanzapine 15mg tablets28£3.84
Olanzapine 20mg tablets28£4.60
Prochlorperazine 5mg tablets28£1.30
Rasagiline 1mg tablets28£7.20
Senna 7.5mg tablets60£2.50
Tamoxifen 20mg tablets30£10.50

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less